AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03078816 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DBS Extension - (Models 37085/6)
Description: Deep Brain Stimulator system will be implanted using standard neurosurgical techniques. The device will deliver constant stimulation to the thalamus using settings programmed by study team.
Study NCT03078816 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Patient Programmer - (Model 37642)
Description: Deep Brain Stimulator system will be implanted using standard neurosurgical techniques. The device will deliver constant stimulation to the thalamus using settings programmed by study team.
Study NCT03078816 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Test Stimulator - (Model 3625)
Description: Deep Brain Stimulator system will be implanted using standard neurosurgical techniques. The device will deliver constant stimulation to the thalamus using settings programmed by study team.
Study NCT01557647 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Inhaled treprostinil
Description: 0.6mg/mL treprostinil for inhalation solution. Titrated up to 12 breaths QID.
Study NCT01557647 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo inhalation solution
Study NCT03731182 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: V114
Description: V114 pneumococcal capsular polysaccharide serotypes 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19F, 19A, 22F, 23F, 33F (2 mcg each), and serotype 6B (4 mcg) in each 0.5 mL dose
Study NCT03731182 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Prevnar 13™
Description: Prevnar 13™ pneumococcal capsular polysaccharide serotypes 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F, 23F (2.2 mcg) and 6B (4.4 mcg) in each 0.5 ml dose
Study NCT03788577 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oligonol intake
Description: Major intervention of Oligonol component , as suggested Oligonol safe dose for adults is 200mg per day.
Study NCT03078816 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: N'Vision Clinician Programmer - (Model 8840)
Description: Deep Brain Stimulator system will be implanted using standard neurosurgical techniques. The device will deliver constant stimulation to the thalamus using settings programmed by study team.
Study NCT02679079 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NBI-98854
Study NCT03078816 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: N'Vision Software Application Card - (Model 8870)
Description: Deep Brain Stimulator system will be implanted using standard neurosurgical techniques. The device will deliver constant stimulation to the thalamus using settings programmed by study team.
Study NCT01581723 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Monopolar diathermy
Description: monopolar diathermy
Study NCT01581723 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bipolar diathermy
Description: bipolar diathermy
Study NCT03781921 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: There is no intervention. Each group will conduct the same tasks and questionnaires and we will compare performances between groups.
Study NCT02461810 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vertebral fracture surgery SpineJack®
Description: Vertebral augmentation for one osteoporotic vertebral compression fracture
Study NCT02461810 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Balloon Kyphoplasty
Study NCT01727063 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cell Therapy
Description: Intramyocardial injection of autologous bone marrow-derived cells
Study NCT02679079 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT01295775 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: sulodexide
Description: A (SULODEXIDE GROUP):~50 mg a day by oral route (1+1 capsules/day) for 360 days~B (PLACEBO GROUP):~Sulodexide placebo at the same schedule dosage and for the same lengths of time as group A.
Study NCT03886259 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neuromuscular exercises (NEMEX-TJR) and pain neuroscience education
Description: 60min. of neuromuscular exercises (NEMEX-TJR) training two times a week for 3 months (12 weeks, 24 sessions). Physiotherapists will instruct and supervise the participants during the neuromuscular exercises. The aim of the neuromuscular exercise program is to restore normal movement, improve sensorimotor control, re-establishing normal motor program strategies and muscle activation.~60min. of pain neuroscience education at the beginning of intervention period and after 6 weeks. Both sessions will take 60min. and will be conducted by physiotherapists. The aim of the pain neuroscience education is to increase the pain neuroscience knowledge of the patients leading to a better understanding of their chronic pain and thereby engaging the patients in the treatment of their chronic pain and impaired function.
Study NCT03886259 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pain neuroscience education
Description: 60min. of pain neuroscience education at the beginning of intervention period and after 6 weeks. Both sessions will take 60min. and will be conducted by physiotherapists. The aim of the pain neuroscience education is to increase the pain neuroscience knowledge of the patients leading to a better understanding of their chronic pain and thereby engaging the patients in the treatment of their chronic pain and impaired function.
Study NCT01778556 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Metreleptin
Description: Recombinant analog of the human hormone, leptin
Study NCT01295775 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: sulodexide
Description: A (SULODEXIDE GROUP):~50 mg a day by oral route (1+1 capsules/day) for 360 days~B (PLACEBO GROUP):~Sulodexide placebo at the same schedule dosage and for the same lengths of time as group A.
Study NCT02358499 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Posaconazole
Description: Posaconazole will be given as a one time intravenous (IV) dose. The dose will take ninety (90) minutes to be infused and will be based on weight at the time of the visit.
Study NCT03329703 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Project UPLIFT
Description: A group, telephone-based intervention for depression that uses techniques from mindfulness-based therapy and cognitive therapy. The intervention consists of 8 sessions occurring at the same time and day every week.
Study NCT03329703 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Project UPLIFT
Description: A group, telephone-based intervention for depression that uses techniques from mindfulness-based therapy and cognitive therapy. The intervention consists of 8 sessions occurring at the same time and day every week.
Study NCT00950443 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Acoustic reflection method
Description: Acoustic reflection gives the longitudinal cross-sectional area profile along airway.Based on planar acoustic wave propagating in a rigid duct connected to airway.
Study NCT00950443 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acoustic method and breathing/endoscopic evaluation
Description: Endoscopic evaluation done under general anaesthesia.
Study NCT06018298 — intervention group
Intervention type: OTHER
Intervention: Treatment as usual (TAU)
Description: the components of treatment as usual (TAU) are summarised and assessed by the items of the DUNDRUM-3: physical health, mental health, substance misuse, problem behaviours, self care and activities of daily living, education occupation and creativity, family and intimacy.
Study NCT00312260 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gabapentin
Description: Gabapentin will be prescribed at 900mg/d (300mg tid). A dose escalation schedule will be followed: one pill taken at night (\~2000h) for the first 3 days, one pill at night and one pill in the morning (\~0800h) for the second 3 days and finally, one pill at night, one in the morning and one mid-afternoon (\~1400h) for the reminder of the trial.
Study NCT00312260 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amitriptyline
Description: Amitriptyline will be prescribed at a dose of 10mg (qhs). A dose escalation schedule will be followed: one pill taken at night (\~2000h) for the first 3 days, one pill at night and one pill in the morning (\~0800h) for the second 3 days and finally, one pill at night, one in the morning and one mid-afternoon (\~1400h) for the reminder of the trial.
Study NCT03788577 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT03208426 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esomeprazole (S14)
Description: Nexium, esomeprazole 40mg bid, 14 days
Study NCT03208426 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Esomeprazole (BQ10)
Description: Nexium, esomeprazole, 40mg bid for 10 days
Study NCT03208426 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin (ST14)
Description: Day 1-7 amoxicillin (Brand name: Amoxicillin Capsule) 1000mg bid for 7 days
Study NCT03208426 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clarithromycin (ST14)
Description: Klaricid-XL, clarithromycin, 500mg, bid, for 7 days, (day 8-14)
Study NCT03208426 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metronidazole (ST14)
Description: Flagyl, metronidazole, 500mg bid, for 7 days (day 8-14)
Study NCT03221725 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: sacrospinous ligament fixation
Description: sacrospinous ligament fixation will be applied to prevent vaginal vault prolapse
Study NCT03066401 — intervention group
Intervention type: PROCEDURE
Intervention: echography
Description: The inferior vena cava and the internal jugular vein diameters were measured by echography before and after blood withdrawal during a standardized respiratory maneuver
Study NCT00593125 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: levetiracetam
Description: The participants will start receiving Levetiracetam 500mg in the mornings of the first day on week 2. The dose will be titrated every third day, until the target dose of 3000mg/day is achieved by week 4. The study medication must be titrated to 3000 mg/day or to the subject's maximum tolerated dose (MTD). The physician overseeing this titration as well as all study staff will not be blind to the subject's medication administration. The medication will be discontinued over a two-week period
Study NCT03188120 — intervention group
Intervention type: DRUG
Intervention: Spiriva Respimat
Description: Drug
Study NCT05488275 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgery
Description: MPFL reconstruction
Study NCT03606304 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Problem-solving therapy
Description: See previous
Study NCT03871946 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: oral glucose tolerance test (OGTT)
Description: Implementation of OGTT: The patient was seated in a quiet room after 10-12 h of overnight fasting, and blood samples were drawn. Thereafter, 75 g glucose solution dissolved in 300 mL of water was administeredwithin 5 min. Two hours after this,another blood sample was drawn. During the test, the patient wasn't allowed to rest and eat, but not smoke.
Study NCT00538928 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: lung protective ventilation
Description: tidal volume 6 ml/kg ideal body weight
Study NCT00538928 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: lung protective ventilation
Description: tidal volume 6 ml/kg ideal body weight
Study NCT01540214 — intervention group
Intervention type: OTHER
Intervention: Pre- and postoperative evaluations
Description: At baseline before surgery and at 6 and 12 months after surgery: questionnaires, bladder diary, pelvic examination with additional ultrasound (one extra outpatient clinic visit at 6 months compared to standard care).~At baseline before surgery and at 12 months after surgery: urodynamics with additional urine sampling (one extra outpatient clinic visit at 12 months compared to standard care).~At time of surgery: additional cystoscopy.
Study NCT00871650 — intervention group
Intervention type: OTHER
Intervention: Sleep data recording
Description: After completing the screening procedures, eligible participants will sleep in the laboratory for three consecutive nights of EEG sleep studies, one waking \[18F\]-FDG PET scan, and one REM sleep PET scan according to published methods.
Study NCT00871650 — intervention group
Intervention type: OTHER
Intervention: PET scan - waking
Description: After completing the screening procedures, eligible participants will sleep in the laboratory for three consecutive nights of EEG sleep studies, one waking \[18F\]-FDG PET scan, and one REM sleep PET scan according to published methods.
Study NCT00871650 — intervention group
Intervention type: OTHER
Intervention: PET scan - REM Sleep
Description: After completing the screening procedures, eligible participants will sleep in the laboratory for three consecutive nights of EEG sleep studies, one waking \[18F\]-FDG PET scan, and one REM sleep PET scan according to published methods.
Study NCT02440347 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Computer controlled anesthetic delivery by Anaeject
Description: Single dose of 0.6ml 4% articaine with epinephrine (1:100.000) delivered by computer controlled local anesthetic delivery system (Anaeject).
Study NCT02440347 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional anesthetic delivery by carpule syringe
Description: Single dose of 0.6ml 4% articaine with epinephrine (1:100.000) delivered by conventional syringe (carpule syringe).
Study NCT02012062 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TPF neoadjuvant chemotherapy
Study NCT02012062 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TPF neoadjuvant chemotherapy
Study NCT02012062 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Concurrent chemotherapy with cisplatin during radiotherapy
Study NCT02012062 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Concurrent nimotuzumab during radiotherapy
Study NCT02012062 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radical radiotherapy
Study NCT02012062 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radical radiotherapy
Study NCT00782496 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Education + new meter
Description: Diabetes education and a new meter with basic features
Study NCT00782496 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Education + new meter + feature activation
Description: Diabetes education and a new meter with advanced features
Study NCT04410068 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WARMTAC
Description: Randomization to one of the arms previous to surgery.
Study NCT04410068 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 3M Bair Hugger
Description: Randomization to one of the arms previous to surgery.
Study NCT03703583 — intervention group
Intervention type: OTHER
Intervention: There is no intervention in this observational study.
Description: There is no intervention in this observational study.
Study NCT00878202 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SCAD information system
Description: Clinical follow-up and continuation of therapeutic education by telemedicine during 3 months
Study NCT00749307 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid (DHA)
Study NCT00749307 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT03055481 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High irradiance level of phototherapy
Description: High irradiance level of phototherapy: the target irradiance level is 30-35uW per square centimeter per nanometer of wavelength.
Study NCT02138266 — intervention group
Intervention type: DEVICE
Intervention: Topcon Specular Microscope SP-1P
Study NCT02138266 — intervention group
Intervention type: DEVICE
Intervention: Konan Specular Microscope CELLCHEK XL
Study NCT03055481 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low irradiance level of phototherapy
Description: Low irradiance level of phototherapy: the target irradiance level is 12-15uW per square centimeter per nanometer of wavelength
Study NCT03687398 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: genetic testing with nanoclonal technique
Description: endometrial sampling
Study NCT00462137 — intervention group
Intervention type: PROCEDURE
Intervention: Sleep Studies
Study NCT02551770 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Scaling and root planing
Description: Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw.
Study NCT02551770 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Scaling and root planing without Emdogain
Description: Using minimally invasive surgical procedure (scaling and root planing) without Emdogain application to treat one contra-lateral quadrant in subject's jaw.
Study NCT02551770 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Emdogain application
Description: Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw
Study NCT03979053 — intervention group
Intervention type: DEVICE
Intervention: Multiparametric MRI Scan
Description: Patients attending the clinic will have a MRI scan added to their standard of care.
Study NCT03575338 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Open Scarf Osteotomy
Description: Open Scarf Osteotomy
Study NCT03575338 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Minimally invasive scarf Osteotomy
Description: Minimally invasive scarf Osteotomy
Study NCT03129048 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MedDiet
Description: Research subjects will be randomly assigned to one of three intervention groups.~The MedDiet-A group will learn about and how to adhere to the Mediterranean Diet. Over the course of 8 months, they will receive twenty-two classes 60-minute in length.~The MedDiet-WL group will learn about the Mediterranean Diet, how to adhere to is and engage in lifestyle choices like exercising and eating fewer calories so that they will loose weight. Over the course of 8 months they will receive 22 classes, each 90 minutes in length.~The Typical Diet Control group will be asked to maintain current eating and activity patterns over the course of the 14 month study.
Study NCT02895113 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: Patients suffering from type 2 diabetes will be randomized to receive 100 mg/day or placebo for one year
Study NCT03684356 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: socket shield technique
Description: immediate implant placement with buccal part of the root is retained
Study NCT03684356 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: xenograft
Description: immediate implant placement with filling the buccal gap with xenograft
Study NCT03208426 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dibismuth trioxide 120mg (BQ10)
Description: KCB F.C. TABLETS, dibismuth trioxide 120mg qid for 10 days
Study NCT03208426 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metronidazole (BQ10)
Description: Flagyl, metronidazole 500mg tid for 10 days
Study NCT03129048 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: MedDiet
Description: Research subjects will be randomly assigned to one of three intervention groups.~The MedDiet-A group will learn about and how to adhere to the Mediterranean Diet. Over the course of 8 months, they will receive twenty-two classes 60-minute in length.~The MedDiet-WL group will learn about the Mediterranean Diet, how to adhere to is and engage in lifestyle choices like exercising and eating fewer calories so that they will loose weight. Over the course of 8 months they will receive 22 classes, each 90 minutes in length.~The Typical Diet Control group will be asked to maintain current eating and activity patterns over the course of the 14 month study.
Study NCT03453528 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 68Ga-PSMA
Description: 68Ga-PSMA will be injected intravenously via an indwelling catheter in an antecubital vein; (68Ga-PSMA activity: min 100 MBq - max 200 MBq, weighted activity: 2.0 MBq/Kg).
Study NCT02895113 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients in this arm will be treated with placebo
Study NCT02881489 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biological: Cell-based therapy
Description: Human autologous bone marrow-derived mesenchymal stem cell transplantation in ALS patients.
Study NCT04557826 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RD19
Description: Experimental device that uses safe electromagnetic energy to stimulate the proximal repository of respiratory tract infectious disease pathogens
Study NCT01237795 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dentifrice
Description: Dentifrices (4 formulations) used as auxiliary agents for brushing complete dentures.
Study NCT01237795 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dentifrice
Description: Dentifrices (4 formulations) used as auxiliary agents for brushing complete dentures.
Study NCT03402516 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 18.5 resector
Description: hysteroscopic myomectomy with a 18.5 Fr resector after cervical dilatation until Hegar bougie number 7